New data-driven, commercial platform for medical technology companies fills market need in a fast-growing industry, forecasted CAGR of 5.5% through 2029

BOSTON–(BUSINESS WIRE)–AcuityMD, providers of a novel commercial platform for medical technology (MedTech) companies, is ending 2022 with impressive business, customer, and employee growth. Founded in 2019, the start-up increased its annual recurring revenue (ARR) by 317%, customer growth by 253%, and new hires by 246%. For comparison, the average revenue growth rate for B2B software companies in the U.S. between two and four years of age is currently 82%.

“AcuityMD’s commercial platform drives this expense way down by strategically identifying high-value opportunities and surgeon profiles, which ultimately empowers doctors with best-in-class technology and improves access to advanced healthcare.”

Tweet this

“It’s incredibly rewarding to experience AcuityMD’s steady growth,” said Mike Monovoukas, founder and CEO of AcuityMD. “We…

Read Full Story: